메뉴 건너뛰기




Volumn 77, Issue 7, 1998, Pages 777-781

Prognosis of 2800 patients with epithelial ovarian cancer diagnosed during 1975-94 and treated at the Norwegian Radium Hospital

Author keywords

Epithelial ovarian cancer; Prognosis

Indexed keywords

ARTICLE; CANCER STAGING; CANCER SURVIVAL; EPITHELIUM; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MORTALITY; NORWAY; OVARY CANCER; PRIORITY JOURNAL; PROGNOSIS; RISK ASSESSMENT; STATISTICAL MODEL; ADOLESCENT; ADULT; AGED; CARCINOMA; MIDDLE AGED; MULTIVARIATE ANALYSIS; OVARY TUMOR; SURVIVAL; TREATMENT OUTCOME;

EID: 0031874096     PISSN: 00016349     EISSN: None     Source Type: Journal    
DOI: 10.1080/j.1600-0412.1998.770714.x     Document Type: Article
Times cited : (42)

References (19)
  • 1
    • 0027173231 scopus 로고
    • Estimates of the worldwide incidence of eighteen major cancers in 1985
    • Parkin DM, Pisani P, Ferlay J. Estimates of the worldwide incidence of eighteen major cancers in 1985. Int J Cancer 1993; 54: 594-606.
    • (1993) Int J Cancer , vol.54 , pp. 594-606
    • Parkin, D.M.1    Pisani, P.2    Ferlay, J.3
  • 2
    • 0025104871 scopus 로고
    • Trends and differentials in ovarian cancer: Incidence, mortality and survival experience
    • Hanai A. Trends and differentials in ovarian cancer: incidence, mortality and survival experience. APMIS Suppl 1990; 12: 1-20.
    • (1990) APMIS Suppl , vol.12 , pp. 1-20
    • Hanai, A.1
  • 3
    • 0030914791 scopus 로고    scopus 로고
    • Trends in the incidence of ovarian cancer and borderline tumours in Norway, 1954-93
    • Bjørge T, Engeland A, Hansen S, Tropé CG. Trends in the incidence of ovarian cancer and borderline tumours in Norway, 1954-93. Int J Cancer 1997; 71: 780-6.
    • (1997) Int J Cancer , vol.71 , pp. 780-786
    • Bjørge, T.1    Engeland, A.2    Hansen, S.3    Tropé, C.G.4
  • 5
    • 0032473544 scopus 로고    scopus 로고
    • Prognosis of patients with ovarian cancer and borderline tumours diagnosed in Norway between 1954 and 1993
    • Bjørge T, Engeland A, Hansen S, Tropé CG. Prognosis of patients with ovarian cancer and borderline tumours diagnosed in Norway between 1954 and 1993. Int J Cancer 1998; 75: 663-70.
    • (1998) Int J Cancer , vol.75 , pp. 663-670
    • Bjørge, T.1    Engeland, A.2    Hansen, S.3    Tropé, C.G.4
  • 6
    • 0031026893 scopus 로고    scopus 로고
    • Epithelial ovarian carcinoma
    • Kristensen GB, Tropé C. Epithelial ovarian carcinoma. Lancet 1997; 349: 113-17.
    • (1997) Lancet , vol.349 , pp. 113-117
    • Kristensen, G.B.1    Tropé, C.2
  • 13
    • 0021868905 scopus 로고
    • The Will Rogers phenomenon. Stage migration and new diagnostic techniques as a source of misleading statistics for survival in cancer
    • Feinstein AR, Sosin DM, Wells CK. The Will Rogers phenomenon. Stage migration and new diagnostic techniques as a source of misleading statistics for survival in cancer. N Engl J Med 1985; 312: 1604-8.
    • (1985) N Engl J Med , vol.312 , pp. 1604-1608
    • Feinstein, A.R.1    Sosin, D.M.2    Wells, C.K.3
  • 14
    • 0016586897 scopus 로고
    • Surgical resection of tumor bulk in the primary treatment of ovarian cancer
    • Griffiths CTH. Surgical resection of tumor bulk in the primary treatment of ovarian cancer. Natl Cancer Inst Monogr 1975; 42: 101-4.
    • (1975) Natl Cancer Inst Monogr , vol.42 , pp. 101-104
    • Griffiths, C.T.H.1
  • 15
    • 0029050211 scopus 로고
    • A meta-analysis of residual disease and survival in stage III and IV carcinoma of the ovary
    • Allen DG, Heintz AP, Touw FW. A meta-analysis of residual disease and survival in stage III and IV carcinoma of the ovary. Eur J Gynaecol Oncol 1995; 16: 349-56.
    • (1995) Eur J Gynaecol Oncol , vol.16 , pp. 349-356
    • Allen, D.G.1    Heintz, A.P.2    Touw, F.W.3
  • 16
    • 0018239343 scopus 로고
    • Advanced ovarian adenocarcinoma. A prospective clinical trial of melphalan (L-PAM) versus combination chemotherapy
    • Young RC, Chabner BA, Hubbard SP. Fisher RI, Bender RA, Anderson T et al. Advanced ovarian adenocarcinoma. A prospective clinical trial of melphalan (L-PAM) versus combination chemotherapy. N Engl J Med 1978; 299: 1261-6.
    • (1978) N Engl J Med , vol.299 , pp. 1261-1266
    • Young, R.C.1    Chabner, B.A.2    Hubbard, S.P.3    Fisher, R.I.4    Bender, R.A.5    Anderson, T.6
  • 18
    • 0019788593 scopus 로고
    • Use of high dose cis-dichlorodiammineplatinum (II) (NSC-119875) following failure on previous chemotherapy for advanced carcinoma of the ovary
    • Barker GJ, Wiltshaw E. Use of high dose cis-dichlorodiammineplatinum (II) (NSC-119875) following failure on previous chemotherapy for advanced carcinoma of the ovary. Br J Obstet Gynaecol 1981; 88: 1192-6.
    • (1981) Br J Obstet Gynaecol , vol.88 , pp. 1192-1196
    • Barker, G.J.1    Wiltshaw, E.2
  • 19
    • 0030054309 scopus 로고    scopus 로고
    • Cyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage III and stage IV ovarian cancer
    • McGuire WP, Hoskins WJ, Brady MF, Kucera PR, Partridge EE, Look KY et al. Cyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage III and stage IV ovarian cancer. N Engl J Med 1996; 334: 1-6.
    • (1996) N Engl J Med , vol.334 , pp. 1-6
    • McGuire, W.P.1    Hoskins, W.J.2    Brady, M.F.3    Kucera, P.R.4    Partridge, E.E.5    Look, K.Y.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.